Left Main Coronary Interventions: A Practical Guide.


Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
12 2020
Historique:
received: 23 03 2020
revised: 12 05 2020
accepted: 12 05 2020
pubmed: 18 6 2020
medline: 13 8 2021
entrez: 18 6 2020
Statut: ppublish

Résumé

Coronary artery bypass surgery has been the accepted treatment for left main coronary artery disease for over 50 years. Balloon angioplasty was later used then abandoned because of deaths likely due to restenosis or thrombotic occlusion. However, rapid innovations in drug-eluting stent designs leading to more biocompatible thin strut platforms with optimal drug elution profiles and further advances in modern pharmacotherapy involving potent P2Y

Identifiants

pubmed: 32546382
pii: S1553-8389(20)30261-X
doi: 10.1016/j.carrev.2020.05.014
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1596-1605

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Bill D Gogas (BD)

The Spencer B. King III Catheterization Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: http://twitter.com/@billgogas.

Ye Fei (Y)

The Spencer B. King III Catheterization Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Lin Song (L)

The Spencer B. King III Catheterization Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Dimitrios Alexopoulos (D)

Division of Cardiology, Interventional Cardiology, ATTIKON Hospital, University of Athens Medical School, Athens, Greece.

Francesco Lavarra (F)

Jilin Heart Hospital, Changchun, Jilin, China.

Tanveer Rab (T)

Emory University School of Medicine, Atlanta, GA, USA.

Spencer B King (SB)

Emory University School of Medicine, Atlanta, GA, USA.

Shao-Liang Chen (SL)

The Spencer B. King III Catheterization Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH